ABSTRACT
About Allergy Rhinitis Drugs
Allergic rhinitis refers to the inflammation of nasal membranes that causes nasal congestion, sneezing, itching, and rhinorrhea. This condition is usually caused by dust, animal dander, pollen, and certain food ingredients. Allergic rhinitis or hay fever occurs when the immune system overreacts to allergens in the air such as dust, animal dander, or pollen. Symptoms can also occur due to various food allergies.
Technavio’s analysts forecast the global allergy rhinitis drugs market to grow at a CAGR of 3.05% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global allergy rhinitis drugs market for 2017-2021. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Allergy Rhinitis Drugs Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• GlaxoSmithKline
• Sanofi
• ALK-Abelló
• Meda Pharmaceuticals
Other prominent vendors
• Adamis Pharmaceuticals
• Allergy Therapeutics
• Almirall
• Ampio
• AstraZeneca
• Amneal Pharmaceuticals
• Anergis
• Apotex
• Array BioPharma
• Aspen Pharmacare
• Circassia Pharmaceuticals
• Dr Reddy's Laboratories
• Eddingpharm
• EMS
• HAL Allergy
• Inmunotek
• Genentech
• Greer Laboratories
• Glenmark Pharmaceuticals
• Hanmi Pharmaceuticals
• Hisamitsu Pharmaceutical
• Intas Pharmaceuticals
• Novartis
• Nuvo Research
• Nycomed
• Omega Pharma
• Shionogi
• Stallergenes
• Sun Pharmaceuticals
• Takeda
• Teva Pharmaceuticals
• Verona Pharma
• VentiRx Pharmaceuticals
Market driver
• Increasing awareness about allergic rhinitis
• For a full, detailed list, view our report
Market challenge
• Patent expiries and generic competition
• For a full, detailed list, view our report
Market trend
• Increase in R&D activities
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Table of Contents
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Research Methodology
PART 04: Introduction
• Market outline
PART 05: Pipeline Landscape
PART 06: Market landscape
• Market overview
PART 07: Market segmentation by drug class
• Global allergy rhinitis antihistamines market
• Global allergy rhinitis intranasal corticosteroids market
• Global allergy rhinitis immunotherapies market
• Others
PART 08: Geographical segmentation
• Allergy rhinitis drugs market in Americas
• Allergy rhinitis drugs market in EMEA
• Allergy rhinitis drugs market in APAC
PART 09: Decision framework
PART 10: Drivers and challenges
• Market drivers
• Market challenges
PART 11: Market trends
• Strategic alliances
• Increase in R&D activities
• Self-medication using OTC products
PART 12: Vendor Landscape
• Competitive landscape
PART 13: Vendor landscape
• GlaxoSmithKline
• Sanofi
• ALK-Abelló
• Meda Pharmaceuticals
• Other prominent vendors
PART 14: Appendix
• List of abbreviations
List of Exhibits
Exhibit 01: Types of allergic rhinitis
Exhibit 02: Risk factors associated with allergic rhinitis
Exhibit 03: Key pipeline candidates by vendor and number of drugs
Exhibit 04: Pipeline analysis
Exhibit 05: Global allergy rhinitis drugs market snapshot
Exhibit 06: Global allergy rhinitis drugs market 2016-2021 ($ millions)
Exhibit 07: Five forces analysis
Exhibit 08: Global allergy rhinitis drugs market: Segmentation by drug class
Exhibit 09: Global allergy rhinitis antihistamines market 2016-2021 ($ millions)
Exhibit 10: Global allergy rhinitis intranasal corticosteroids market 2016-2021 ($ millions)
Exhibit 11: Global allergic rhinitis immunotherapies market 2016-2021 ($ millions)
Exhibit 12: Global allergy rhinitis drugs market by geography 2016 and 2021
Exhibit 13: Global allergy rhinitis drugs market revenue by geography 2016-2021 ($ millions)
Exhibit 14: Market scenario in Americas
Exhibit 15: Allergy rhinitis drugs market in Americas ($ millions)
Exhibit 16: Market scenario in EMEA
Exhibit 17: Allergy rhinitis drugs market in EMEA 2016-2021 ($ millions)
Exhibit 18: Market scenario in APAC
Exhibit 19: Allergy rhinitis drugs market in APAC 2016-2021 ($ millions)
Exhibit 20: Drugs that underwent prescription-to-OTC switch in the US
Exhibit 21: Competitive structure analysis of global allergy rhinitis drugs market 2016
Exhibit 22: GlaxoSmithKline: Key highlights
Exhibit 23: GlaxoSmithKline: Strength assessment
Exhibit 24: GlaxoSmithKline: Strategy assessment
Exhibit 25: GlaxoSmithKline: Opportunity assessment
Exhibit 26: Sanofi: Key highlights
Exhibit 27: Sanofi: Strength assessment
Exhibit 28: Sanofi: Strategy assessment
Exhibit 29: Sanofi: Opportunity assessment
Exhibit 30: ALK-Abelló: Key highlights
Exhibit 31: ALK-Abelló: Strength assessment
Exhibit 32: ALK-Abelló: Strategy assessment
Exhibit 33: ALK-Abelló: Opportunity assessment
Exhibit 34: Meda Pharmaceuticals: Key highlights
Exhibit 35: Meda Pharmaceuticals: Strength assessment
Exhibit 36: Meda: Strategy assessment
Exhibit 37: Meda: Opportunity assessment
